骨髓状肉瘤:关于分子病变发生,呈现和治疗选择的新进展
1Thalassemia and Sickle Cell Disease Unit, Department of Hematology, 1st Department of Internal Medicine, General Hospital of Larissa, Tsakalov Str. 1, 41 221 Larissa, Greece.
Journal of clinical medicine
|October 26, 2024
概括
骨髓性瘤 (MS),一种外骨髓性急性骨髓性白血病 (AML),存在诊断和治疗方面的挑战. 本综述详细介绍了MS诊断,分子洞察,临床表现和治疗策略的最新进展,包括化疗和干细胞移植.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 骨髓性肉瘤 (MS) 是一种罕见的外骨髓性瘤,由骨髓性爆发组成,代表一种急性骨髓性白血病 (AML) 的形式.
- 多发性硬化可能伴有或没有骨髓干扰,呈现为同步或孤立的疾病.
- 它传播到各种解剖部位,造成诊断和治疗的复杂性.
研究的目的:
- 审查最近在诊断,分子背景,临床表现和骨髓状肉瘤治疗方面的进展.
- 为个人多发性硬化患者提供治疗决策的批判性分析,考虑新的向AML疗法.
- 讨论中枢神经系统 (中枢神经系统) 预防和治疗不耐治,复发或难以治疗的MS病例的管理策略.
主要方法:
- 文献综述,重点介绍了髓性肉瘤研究的近期进展.
- 分析诊断标准,分子标记物和不同器官参与的临床表现.
- 评估当前和新兴的治疗方式,包括化疗,放射疗法和造血干细胞移植 (HSCT).
主要成果:
- 由于MS的罕见性和不同的临床表现,诊断MS仍然具有挑战性.
- 标准治疗通常涉及AML诱导化疗,随后是HSCT.
- 针对性AML疗法正在影响MS治疗决策,同时考虑中枢神经系统预防和特定地点的管理.
结论:
- 骨髓性肉瘤的最佳管理需要采用多学科的方法,整合最近的分子和临床发现.
- 造血干细胞移植是许多多发性硬化症患者的关键治疗选择.
- 需要进一步的研究和前性试验来完善这种罕见的AML表现的治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K